Y. Foong

The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.

J. Dillner, T. Lehtinen, P. Depaoli, 1995, The Journal of general virology.

Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay.

J. Dillner, U. Prasad, C. Sam, 1993, Journal of virological methods.

Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors

J. Dillner, U. Prasad, C. Sam, 1991, Journal of clinical microbiology.

Serum and salivary IgA antibodies against a defined epitope of the Epstein‐Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma

J. Dillner, U. Prasad, C. Sam, 1990, International journal of cancer.

Linear epitopes of the replication-activator protein of Epstein-Barr virus recognised by specific serum IgG in nasopharyngeal carcinoma

J. Dillner, U. Prasad, C. Sam, 1995, Cancer Immunology, Immunotherapy.